Prediction of maintenance of sinus rhythm after electrical cardioversion of atrial fibrillation by non-deterministic modelling.

AIMS Atrial fibrillation (AF) is the most common rhythm disorder. Because of the high recurrence rate of AF after cardioversion and because of potential side effects of electrical cardioversion, it is clinically important to predict persistence of sinus rhythm after electrical cardioversion before it is attempted. The aim of our study was the development of a mathematical model by "genetic" programming (GP), a non-deterministic modelling technique, which would predict maintenance of sinus rhythm after electrical cardioversion of persistent AF. PATIENTS AND METHODS Ninety-seven patients with persistent AF lasting more than 48h, undergoing the first attempt at transthoracic cardioversion were included in this prospective study. Persistence of AF before the cardioversion attempt, amiodarone treatment, left atrial dimension, mean, standard deviation and approximate entropy of ECG R-R intervals were collected. The data of 53 patients were randomly selected from the database and used for GP modelling; the other 44 data sets were used for model testing. RESULTS In 23 patients sinus rhythm persisted at 3 months. In the other 21 patients sinus rhythm was not achieved or its duration was less than 3 months. The model developed by GP failed to predict maintenance of sinus rhythm at 3 months in one patient and in six patients falsely predicted maintenance of sinus rhythm. Positive and negative likelihood ratios of the model for testing data were 4.32 and 0.05, respectively. Using this model 15 of 21 (71.4%) cardioversions not resulting in sinus rhythm at 3 months would have been avoided, whereas 22 of 23 (95.6%) cardioversions resulting in sinus rhythm at 3 months would have been administered. CONCLUSION This model developed by GP, including clinical data, ECG data from the time-domain and nonlinear dynamics can predict maintenance of sinus rhythm. Further research is needed to explore its utility in the present or an expanded form.

[1]  S. Hohnloser,et al.  Impact of rate versus rhythm control on quality of life in patients with persistent atrial fibrillation. Results from a prospective randomized study. , 2003, European heart journal.

[2]  D. Levy,et al.  Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. , 1998, Circulation.

[3]  C. Candan,et al.  Contribution of Fabric Characteristics and Laundering to Shrinkage of Weft Knitted Fabrics , 2003 .

[4]  P. Hasselgren,et al.  The selective beta 1-blocking agent metoprolol compared with antithyroid drug and thyroxine as preoperative treatment of patients with hyperthyroidism. Results from a prospective, randomized study. , 1987, Annals of surgery.

[5]  J Haaksma,et al.  Early recurrences of atrial fibrillation after electrical cardioversion: a result of fibrillation-induced electrical remodeling of the atria? , 1998, Journal of the American College of Cardiology.

[6]  A. Mattioli,et al.  Left atrial size after cardioversion for atrial fibrillation: effect of external direct current shock. , 2003, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[7]  S M Pincus,et al.  Approximate entropy as a measure of system complexity. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[8]  Initial energy setting, outcome and efficiency in direct current cardioversion of atrial fibrillation and flutter. , 2001, Journal of the American College of Cardiology.

[9]  S. Lévy,et al.  Prospective assessment of the minimum energy needed for external electrical cardioversion of atrial fibrillation. , 1997, The American journal of cardiology.

[10]  G. Larkin,et al.  Efficacy and impact of monophasic versus biphasic countershocks for transthoracic cardioversion of persistent atrial fibrillation. , 2003, The American journal of cardiology.

[11]  S. Rubin,et al.  Electrical cardioversion resulting in death from synchronization failure. , 1994, The American journal of cardiology.

[12]  S. Nattel,et al.  Amiodarone reduces procedures and costs related to atrial fibrillation in a controlled clinical trial. , 2002, European heart journal.

[13]  T. Grissom,et al.  Titration of intravenous anesthetics for cardioversion: A comparison of propofol, methohexital, and midazolam , 1993, Critical care medicine.

[14]  H. Huikuri,et al.  Heart rate variability and recurrence of atrial fibrillation after electrical cardioversion , 2003, Annals of medicine.

[15]  S Nattel,et al.  Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators. , 2000, The New England journal of medicine.

[16]  Luís de la Fuente,et al.  Factores predictores independientes del éxito agudo y al año de la cardioversión eléctrica en pacientes con fibrilación auricular crónica , 2001 .

[17]  E. Gallagher,et al.  Clinical utility of likelihood ratios. , 1998, Annals of emergency medicine.

[18]  M. Elizari,et al.  Pharmacologic Reversion of Persistent Atrial Fibrillation with Amiodarone Predicts Long-Term Sinus Rhythm Maintenance , 2003, Journal of cardiovascular pharmacology and therapeutics.

[19]  P. Bjerregaard,et al.  Double external direct-current shocks for refractory atrial fibrillation. , 1999, The American journal of cardiology.

[20]  P Coumel,et al.  Paroxysmal atrial fibrillation: a disorder of autonomic tone? , 1994, European heart journal.

[21]  R J Cohen,et al.  Assessment of autonomic regulation in chronic congestive heart failure by heart rate spectral analysis. , 1988, The American journal of cardiology.

[22]  H. Sox,et al.  Clinical prediction rules. Applications and methodological standards. , 1985, The New England journal of medicine.

[23]  Miran Brezocnik,et al.  Using Genetic Programming to Predict the Macroporosity of Woven Cotton Fabrics , 2002 .

[24]  A. Simone,et al.  Verapamil plus antiarrhythmic drugs reduce atrial fibrillation recurrences after an electrical cardioversion (VEPARAF study) , 2004 .

[25]  R. Page,et al.  Initial energy for elective external cardioversion of persistent atrial fibrillation. , 2000, The American journal of cardiology.

[26]  Miran Brezocnik,et al.  A genetic-based approach to simulation of self-organizing assembly , 2001 .

[27]  S. Hohnloser,et al.  Towards a consensus in rate versus rhythm control for management of atrial fibrillation: insights from the PIAF trial. , 2003, Cardiac electrophysiology review.

[28]  Amiodarone to Prevent Recurrence of Atrial Fibrillation , 2000 .

[29]  Wolfgang Banzhaf,et al.  Genetic Programming: An Introduction , 1997 .

[30]  G. Grönefeld.  Comparison of outpatient vs inpatient direct current cardioversion of atrial fibrillation: safety, efficacy and cost savings , 2003 .

[31]  P. Tchou,et al.  Transthoracic cardioversion of atrial fibrillation: comparison of rectilinear biphasic versus damped sine wave monophasic shocks. , 2000, Circulation.

[32]  John R. Koza,et al.  Genetic Programming II , 1992 .

[33]  V. Fuster,et al.  ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conference , 2001, Circulation.

[34]  A. Laupacis,et al.  Clinical prediction rules. A review and suggested modifications of methodological standards. , 1997, JAMA.

[35]  H. Calkins,et al.  A Randomized Comparison of External and Internal Cardioversion of Chronic Atrial Fibrillation , 1992, Circulation.

[36]  I. V. Van Gelder,et al.  Pharmacologic versus direct-current electrical cardioversion of atrial flutter and fibrillation. , 1999, The American journal of cardiology.

[37]  O. Orning,et al.  The efficacy of anticoagulant therapy in preventing embolism related to D.C. electrical conversion of atrial fibrillation. , 1969, The American journal of cardiology.

[38]  J B Martins,et al.  Energy, current, and success in defibrillation and cardioversion: clinical studies using an automated impedance-based method of energy adjustment. , 1988, Circulation.

[39]  D. Levy,et al.  Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. , 1994, JAMA.